Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. Bases follow-up testing on the difference between bilirubin level and the phototherapy threshold. No more risk zones! Raises thresholds for phototherapy and exchange transfusion. Includes gestational age and risk factors for neurotoxicity in the thresholds.

    • Disclaimer

      Disclaimer - BiliTool - Newborn values:

    • BiliTool EMR

      BiliTool EMR | System Status BiliTool EMR allows an...

    • FAQ

      Can I use BiliTool with transcutaneous bilirubin? TcB...

    • Subscribe

      Subscribe - BiliTool - Newborn values:

  2. 19 maj 2010 · This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.

  3. media.gosh.nhs.uk › documents › neonatal_jaundice_NICE_threshold_graphsNeonatal jaundice - media.gosh.nhs.uk

    Neonatal jaundice. Treatment threshold graphs. NICE clinical guideline 98. Developed by the National Collaborating Centre for Women’s and Children’s Health. These treatment threshold graphs accompany the clinical guideline: ‘Neonatal jaundice’. They are also available as an implementation tool.

  4. When using this nomogram, remember that "risk" refers to the risk of a subsequent bilirubin level in that infant >95th percentile for age.

  5. Bilitool (www.bilitool.org) is a web site that provides a free, user-friendly, interactive way to match infant bilirubin levels with the Bhutani nomogram and established phototherapy guidelines (for infants ≥35 weeks)

  6. Clinicians can evaluate a patient’s need for exchange transfusion using graphs in III.F of the Clinical Practice Guidelines, or using Bilitool.org. Decisions to initiate phototherapy or escalate care are guided by the gestational age, the hour-specific TSB, and the

  7. Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.